Medicalgorithmics SA stock news
Medicalgorithmics SA announced that its Ordinary General Meeting (OGM) held on June 19, 2026, successfully approved all proposed resolutions, including the issuance of Series P shares to Biofund Capital Management LLC. This approval facilitates the conversion of a PLN 13.8 million loan into company equity at an issue price of PLN 12.51 per share. The debt--to--equity swap significantly strengthens the company's balance sheet by eliminating major liabilities and follows the previous lack of quorum at the June 8 Extraordinary General Meeting. Additionally, shareholders approved the 2025 financial statements and granted discharge of duties to the Management and Supervisory Boards.